PMC:7068162 / 10290-11295
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 156 | 876-879 | Gene | denotes | had | Gene:23498 |
| 157 | 73-83 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 158 | 289-299 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 159 | 977-987 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T25 | 300-303 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T26 | 522-525 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T27 | 624-627 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T38 | 73-81 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T39 | 289-297 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T40 | 977-985 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T102 | 405-406 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T103 | 433-436 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T104 | 703-709 | http://purl.obolibrary.org/obo/OBI_0000968 | denotes | device |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T30 | 544-551 | Chemical | denotes | reagent | http://purl.obolibrary.org/obo/CHEBI_33893 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T109 | 0-265 | Sentence | denotes | In this study, we demonstrated good analytical performance of an adapted SARS-CoV-2 assay on swab samples with an LoD of 689.3 copies/mL (e.g. 275.72 copies/process) at 95% detection probability, which is roughly in line with results published by Corman et al. [4]. |
| T110 | 266-429 | Sentence | denotes | They report an LoD for SARS-CoV-2 RNA of 5.2 copies per reaction at 95% detection probability, which corresponds to 208 copies/mL based on a 25 µL reaction volume. |
| T111 | 430-749 | Sentence | denotes | It has to be noted that manual determination of LoD usually involves adding purified target RNA directly into the reagent mix for amplification, whereas in our study, control material (purified RNA) was spiked into samples and underwent the full workflow of the cobas 6800 device, including extraction and purification. |
| T112 | 750-826 | Sentence | denotes | Therefore, differences in nominal analytical performance are to be expected. |
| T113 | 827-1005 | Sentence | denotes | One important limitation of the study is that we had to rely on spiked-in material and could not validate the performance of the assay using clinical SARS-CoV-2-positive samples. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32156329-31992387-29322913 | 262-263 | 31992387 | denotes | 4 |
MyTest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32156329-31992387-29322913 | 262-263 | 31992387 | denotes | 4 |